Immediate on‐site interpretation of fine‐needle aspiration smears
BACKGROUND A significant body of literature exists supporting the cost effectiveness of fine‐needle aspiration (FNA) cytology in the work‐up of patients with potential neoplastic disease. Several authorities have stated that immediate, on‐site smear evaluation by cytopathologists optimizes diagnosti...
Gespeichert in:
Veröffentlicht in: | Cancer 2001-10, Vol.93 (5), p.319-322 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 322 |
---|---|
container_issue | 5 |
container_start_page | 319 |
container_title | Cancer |
container_volume | 93 |
creator | Layfield, Lester J. Bentz, Joel S. Gopez, Evelyn V. |
description | BACKGROUND
A significant body of literature exists supporting the cost effectiveness of fine‐needle aspiration (FNA) cytology in the work‐up of patients with potential neoplastic disease. Several authorities have stated that immediate, on‐site smear evaluation by cytopathologists optimizes diagnostic accuracy and minimizes the technique's insufficiency rate. This favorable effect on FNA diagnostic accuracy is most pronounced for deep body sites, where FNA is guided by computed tomography (CT), ultrasound, bronchoscopy, or endoscopy. Little data exist regarding whether compensation from Medicare is adequate to support the pathologist in this endeavor compared with other potentially more remunerative activities, including routine surgical pathology sign‐out, nongynecologic cytopathology sign‐out, and frozen section consultation.
METHODS
The authors studied a series of 142 fine‐needle aspirates with immediate, on‐site evaluations performed under a variety of clinical settings. These included bronchoscopic, endoscopic, ultrasound‐guided, and CT‐guided biopsies along with palpation‐directed biopsies performed by either cytopathologists or clinicians. For these aspirates, total pathologist attendance time was calculated and correlated with guidance technique, target organ, location where aspirate was performed, and nature of aspirator. Fifty frozen section evaluations were timed similarly. For comparison purposes, cytopathologists' costs were calculated using the 80th percentile pay level of an associate professor with full‐time clinical duties. Medicare rate schedules were used to calculate compensation. Including salary and benefits, the pathologist cost was approximately $88.83 per hour.
RESULTS
On average, an intraprocedural FNA evaluation for a CT‐guided biopsy required 48.7 minutes, an ultrasound‐guided biopsy required 44.4 minutes of pathologist time, an endoscopic procedure required 56.2 minutes, a bronchoscopic procedure required 55.3 minutes, a clinic aspirate performed by a pathologist required 42.5 minutes, and a clinic FNA performed by a clinician required 34.7 minutes. The average frozen section required 15.7 minutes of pathologist time for performance and interpretation. With the exception of FNA performed in clinic by the cytopathologist, time costs exceeded compensation by $40–50 per procedure. Clinic aspirates performed by a clinician and immediately evaluated by a pathologist resulted in a deficit of approximately $18 over actual time cost.
CO |
doi_str_mv | 10.1002/cncr.9046 |
format | Article |
fullrecord | <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_primary_10_1002_cncr_9046_CNCR9046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CNCR9046</sourcerecordid><originalsourceid>FETCH-LOGICAL-u756-2c8c7782150bd9fb6dec7884e9d36212ba8b7a0ee2a01c9309d4beb1f545de013</originalsourceid><addsrcrecordid>eNotj81KxDAUhYMoOI4ufIO-QGdu0qRpl1JGHRgUZBbuQn5uIdKmJanI7HwEn9EnsWVcnXP44MBHyD2FDQVgWxts3NTAywuyolDLHChnl2QFAFUuePF-TW5S-pinZKJYkd2-79F5PWE2hN_vn-Tn5sOEcYw46ckPIRvarPUBZxoQXYeZTqOPZ5Z61DHdkqtWdwnv_nNNjo-7Y_OcH16f9s3DIf-UosyZrayUFaMCjKtbUzq0sqo41q4oGWVGV0ZqQGQaqK0LqB03aGgruHAItFiT7fn2y3d4UmP0vY4nRUEt7mpxV4u7al6at6UUfzGhUiQ</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immediate on‐site interpretation of fine‐needle aspiration smears</title><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Layfield, Lester J. ; Bentz, Joel S. ; Gopez, Evelyn V.</creator><creatorcontrib>Layfield, Lester J. ; Bentz, Joel S. ; Gopez, Evelyn V.</creatorcontrib><description>BACKGROUND
A significant body of literature exists supporting the cost effectiveness of fine‐needle aspiration (FNA) cytology in the work‐up of patients with potential neoplastic disease. Several authorities have stated that immediate, on‐site smear evaluation by cytopathologists optimizes diagnostic accuracy and minimizes the technique's insufficiency rate. This favorable effect on FNA diagnostic accuracy is most pronounced for deep body sites, where FNA is guided by computed tomography (CT), ultrasound, bronchoscopy, or endoscopy. Little data exist regarding whether compensation from Medicare is adequate to support the pathologist in this endeavor compared with other potentially more remunerative activities, including routine surgical pathology sign‐out, nongynecologic cytopathology sign‐out, and frozen section consultation.
METHODS
The authors studied a series of 142 fine‐needle aspirates with immediate, on‐site evaluations performed under a variety of clinical settings. These included bronchoscopic, endoscopic, ultrasound‐guided, and CT‐guided biopsies along with palpation‐directed biopsies performed by either cytopathologists or clinicians. For these aspirates, total pathologist attendance time was calculated and correlated with guidance technique, target organ, location where aspirate was performed, and nature of aspirator. Fifty frozen section evaluations were timed similarly. For comparison purposes, cytopathologists' costs were calculated using the 80th percentile pay level of an associate professor with full‐time clinical duties. Medicare rate schedules were used to calculate compensation. Including salary and benefits, the pathologist cost was approximately $88.83 per hour.
RESULTS
On average, an intraprocedural FNA evaluation for a CT‐guided biopsy required 48.7 minutes, an ultrasound‐guided biopsy required 44.4 minutes of pathologist time, an endoscopic procedure required 56.2 minutes, a bronchoscopic procedure required 55.3 minutes, a clinic aspirate performed by a pathologist required 42.5 minutes, and a clinic FNA performed by a clinician required 34.7 minutes. The average frozen section required 15.7 minutes of pathologist time for performance and interpretation. With the exception of FNA performed in clinic by the cytopathologist, time costs exceeded compensation by $40–50 per procedure. Clinic aspirates performed by a clinician and immediately evaluated by a pathologist resulted in a deficit of approximately $18 over actual time cost.
CONCLUSIONS
From the current data, it appears that intraprocedural consultations by cytopathologists for CT‐guided, ultrasound‐guided, bronchoscopic, or endoscopic procedures are compensated insufficiently by current Medicare compensation schedules using the CPT code 88172 for on‐site evaluation. Only when the cytopathologist personally performs the aspirate and immediately interprets it (CPT codes 88172 and 88170) does the Medicare payment adequately compensate for professional services. Cancer (Cancer Cytopathol) 2001;93:319–322. © 2001 American Cancer Society.
Although it has been shown that fine‐needle aspiration (FNA) cytology is cost effective and that immediate, on‐site smear evaluation optimizes the diagnostic accuracy of FNA, the authors found that intraprocedural consultations by cytopathologists are undercompensated by current Medicare reimbursement rates.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.9046</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>compensation ; fine‐needle aspiration ; immediate interpretation ; work load</subject><ispartof>Cancer, 2001-10, Vol.93 (5), p.319-322</ispartof><rights>Copyright © 2001 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.9046$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.9046$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids></links><search><creatorcontrib>Layfield, Lester J.</creatorcontrib><creatorcontrib>Bentz, Joel S.</creatorcontrib><creatorcontrib>Gopez, Evelyn V.</creatorcontrib><title>Immediate on‐site interpretation of fine‐needle aspiration smears</title><title>Cancer</title><description>BACKGROUND
A significant body of literature exists supporting the cost effectiveness of fine‐needle aspiration (FNA) cytology in the work‐up of patients with potential neoplastic disease. Several authorities have stated that immediate, on‐site smear evaluation by cytopathologists optimizes diagnostic accuracy and minimizes the technique's insufficiency rate. This favorable effect on FNA diagnostic accuracy is most pronounced for deep body sites, where FNA is guided by computed tomography (CT), ultrasound, bronchoscopy, or endoscopy. Little data exist regarding whether compensation from Medicare is adequate to support the pathologist in this endeavor compared with other potentially more remunerative activities, including routine surgical pathology sign‐out, nongynecologic cytopathology sign‐out, and frozen section consultation.
METHODS
The authors studied a series of 142 fine‐needle aspirates with immediate, on‐site evaluations performed under a variety of clinical settings. These included bronchoscopic, endoscopic, ultrasound‐guided, and CT‐guided biopsies along with palpation‐directed biopsies performed by either cytopathologists or clinicians. For these aspirates, total pathologist attendance time was calculated and correlated with guidance technique, target organ, location where aspirate was performed, and nature of aspirator. Fifty frozen section evaluations were timed similarly. For comparison purposes, cytopathologists' costs were calculated using the 80th percentile pay level of an associate professor with full‐time clinical duties. Medicare rate schedules were used to calculate compensation. Including salary and benefits, the pathologist cost was approximately $88.83 per hour.
RESULTS
On average, an intraprocedural FNA evaluation for a CT‐guided biopsy required 48.7 minutes, an ultrasound‐guided biopsy required 44.4 minutes of pathologist time, an endoscopic procedure required 56.2 minutes, a bronchoscopic procedure required 55.3 minutes, a clinic aspirate performed by a pathologist required 42.5 minutes, and a clinic FNA performed by a clinician required 34.7 minutes. The average frozen section required 15.7 minutes of pathologist time for performance and interpretation. With the exception of FNA performed in clinic by the cytopathologist, time costs exceeded compensation by $40–50 per procedure. Clinic aspirates performed by a clinician and immediately evaluated by a pathologist resulted in a deficit of approximately $18 over actual time cost.
CONCLUSIONS
From the current data, it appears that intraprocedural consultations by cytopathologists for CT‐guided, ultrasound‐guided, bronchoscopic, or endoscopic procedures are compensated insufficiently by current Medicare compensation schedules using the CPT code 88172 for on‐site evaluation. Only when the cytopathologist personally performs the aspirate and immediately interprets it (CPT codes 88172 and 88170) does the Medicare payment adequately compensate for professional services. Cancer (Cancer Cytopathol) 2001;93:319–322. © 2001 American Cancer Society.
Although it has been shown that fine‐needle aspiration (FNA) cytology is cost effective and that immediate, on‐site smear evaluation optimizes the diagnostic accuracy of FNA, the authors found that intraprocedural consultations by cytopathologists are undercompensated by current Medicare reimbursement rates.</description><subject>compensation</subject><subject>fine‐needle aspiration</subject><subject>immediate interpretation</subject><subject>work load</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNotj81KxDAUhYMoOI4ufIO-QGdu0qRpl1JGHRgUZBbuQn5uIdKmJanI7HwEn9EnsWVcnXP44MBHyD2FDQVgWxts3NTAywuyolDLHChnl2QFAFUuePF-TW5S-pinZKJYkd2-79F5PWE2hN_vn-Tn5sOEcYw46ckPIRvarPUBZxoQXYeZTqOPZ5Z61DHdkqtWdwnv_nNNjo-7Y_OcH16f9s3DIf-UosyZrayUFaMCjKtbUzq0sqo41q4oGWVGV0ZqQGQaqK0LqB03aGgruHAItFiT7fn2y3d4UmP0vY4nRUEt7mpxV4u7al6at6UUfzGhUiQ</recordid><startdate>20011025</startdate><enddate>20011025</enddate><creator>Layfield, Lester J.</creator><creator>Bentz, Joel S.</creator><creator>Gopez, Evelyn V.</creator><general>John Wiley & Sons, Inc</general><scope/></search><sort><creationdate>20011025</creationdate><title>Immediate on‐site interpretation of fine‐needle aspiration smears</title><author>Layfield, Lester J. ; Bentz, Joel S. ; Gopez, Evelyn V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-u756-2c8c7782150bd9fb6dec7884e9d36212ba8b7a0ee2a01c9309d4beb1f545de013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>compensation</topic><topic>fine‐needle aspiration</topic><topic>immediate interpretation</topic><topic>work load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Layfield, Lester J.</creatorcontrib><creatorcontrib>Bentz, Joel S.</creatorcontrib><creatorcontrib>Gopez, Evelyn V.</creatorcontrib><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Layfield, Lester J.</au><au>Bentz, Joel S.</au><au>Gopez, Evelyn V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immediate on‐site interpretation of fine‐needle aspiration smears</atitle><jtitle>Cancer</jtitle><date>2001-10-25</date><risdate>2001</risdate><volume>93</volume><issue>5</issue><spage>319</spage><epage>322</epage><pages>319-322</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>BACKGROUND
A significant body of literature exists supporting the cost effectiveness of fine‐needle aspiration (FNA) cytology in the work‐up of patients with potential neoplastic disease. Several authorities have stated that immediate, on‐site smear evaluation by cytopathologists optimizes diagnostic accuracy and minimizes the technique's insufficiency rate. This favorable effect on FNA diagnostic accuracy is most pronounced for deep body sites, where FNA is guided by computed tomography (CT), ultrasound, bronchoscopy, or endoscopy. Little data exist regarding whether compensation from Medicare is adequate to support the pathologist in this endeavor compared with other potentially more remunerative activities, including routine surgical pathology sign‐out, nongynecologic cytopathology sign‐out, and frozen section consultation.
METHODS
The authors studied a series of 142 fine‐needle aspirates with immediate, on‐site evaluations performed under a variety of clinical settings. These included bronchoscopic, endoscopic, ultrasound‐guided, and CT‐guided biopsies along with palpation‐directed biopsies performed by either cytopathologists or clinicians. For these aspirates, total pathologist attendance time was calculated and correlated with guidance technique, target organ, location where aspirate was performed, and nature of aspirator. Fifty frozen section evaluations were timed similarly. For comparison purposes, cytopathologists' costs were calculated using the 80th percentile pay level of an associate professor with full‐time clinical duties. Medicare rate schedules were used to calculate compensation. Including salary and benefits, the pathologist cost was approximately $88.83 per hour.
RESULTS
On average, an intraprocedural FNA evaluation for a CT‐guided biopsy required 48.7 minutes, an ultrasound‐guided biopsy required 44.4 minutes of pathologist time, an endoscopic procedure required 56.2 minutes, a bronchoscopic procedure required 55.3 minutes, a clinic aspirate performed by a pathologist required 42.5 minutes, and a clinic FNA performed by a clinician required 34.7 minutes. The average frozen section required 15.7 minutes of pathologist time for performance and interpretation. With the exception of FNA performed in clinic by the cytopathologist, time costs exceeded compensation by $40–50 per procedure. Clinic aspirates performed by a clinician and immediately evaluated by a pathologist resulted in a deficit of approximately $18 over actual time cost.
CONCLUSIONS
From the current data, it appears that intraprocedural consultations by cytopathologists for CT‐guided, ultrasound‐guided, bronchoscopic, or endoscopic procedures are compensated insufficiently by current Medicare compensation schedules using the CPT code 88172 for on‐site evaluation. Only when the cytopathologist personally performs the aspirate and immediately interprets it (CPT codes 88172 and 88170) does the Medicare payment adequately compensate for professional services. Cancer (Cancer Cytopathol) 2001;93:319–322. © 2001 American Cancer Society.
Although it has been shown that fine‐needle aspiration (FNA) cytology is cost effective and that immediate, on‐site smear evaluation optimizes the diagnostic accuracy of FNA, the authors found that intraprocedural consultations by cytopathologists are undercompensated by current Medicare reimbursement rates.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><doi>10.1002/cncr.9046</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 2001-10, Vol.93 (5), p.319-322 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_wiley_primary_10_1002_cncr_9046_CNCR9046 |
source | Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection |
subjects | compensation fine‐needle aspiration immediate interpretation work load |
title | Immediate on‐site interpretation of fine‐needle aspiration smears |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A40%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immediate%20on%E2%80%90site%20interpretation%20of%20fine%E2%80%90needle%20aspiration%20smears&rft.jtitle=Cancer&rft.au=Layfield,%20Lester%20J.&rft.date=2001-10-25&rft.volume=93&rft.issue=5&rft.spage=319&rft.epage=322&rft.pages=319-322&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.9046&rft_dat=%3Cwiley%3ECNCR9046%3C/wiley%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |